Abstract:The coordinated effect of lipid activated nuclear hormone receptors; liver X receptor (LXR), bound by oxysterol ligands and farnesoid X receptor (FXR), bound by bile acid ligands, act as genetic transcription factors to cause feed-forward cholesterol catabolism to bile acids and feedback repression of bile acid synthesis, respectively. It is the coordinated action of LXR and FXR, each dimerized to retinoid X receptor, that signal nuclear DNA response elements to encode proteins that prevent excessive cholesterol accumulation and bile salt toxicity, respectively. LXR helps prevent hypercholesterolemia by enhancing transporters for cholesterol efflux that enhance reverse cholesterol transport, while FXR enhances intestinal reabsorption and preservation of bile salts by increasing the ileal bile acid binding protein. FXR also targets sodium taurocholate cotransport peptide and bile salt export pump (protein) genes to limit bile salt uptake and enhance export, respectively, which prevents bile salt toxicity. Other nuclear hormone receptors such as pregnan X receptor, which share the obligate partner, retinoid X receptor, and vitamin D receptor also function as bile acid sensors to signal detoxification by hydroxylation of toxic bile acids. Pharmacologically targeted receptor agonists (or antagonists) may be developed that alter cholesterol and bile salt concentrations by modulating nuclear hormone receptors and/or their coactivators or corepressors to positively affect cholesterol homeostasis and bile salt metabolism. It is the coordinated transcription factor action of LXR, which responds to ligand binding of circulating oxysterols in both liver and peripheral tissues, and FXR responding to bile salts within the enterohepatic circulation that make possible the regulation of cholesterol and bile acid homeostasis.

Advance in the research on several nuclear receptors related to bile acid metabolism

Farnesoid X receptor modulators 2014-present: a patent review

The Research Advance of Nuclear Hormone Receptors in Immune Regulation

Nuclear receptors as targets for drug development: regulation of cholesterol and bile acid metabolism by nuclear receptors

Bile acids and their receptors in regulation of gut health and diseases

Role of Bile Acids in Dysbiosis and Treatment of Nonalcoholic Fatty Liver Disease

The regulation of tissue-specific farnesoid X receptor on genes and diseases involved in bile acid homeostasis

Progression in the study on roles of farnesoid X receptor

Bile acids: emerging role in management of liver diseases

Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders

The role of the enterohepatic circulation of bile salts and nuclear hormone receptors in the regulation of cholesterol homeostasis: Bile salts as ligands for nuclear hormone receptors

FXR: structures, biology, and drug development for NASH and fibrosis diseases

Effect of different bile acids on the intestine through enterohepatic circulation based on FXR

Molecular Regulation of Bile Acid Homeostasis

Recent Advances in the Digestive, Metabolic and Therapeutic Effects of Farnesoid X Receptor and Fibroblast Growth Factor 19: From Cholesterol to Bile Acid Signaling

Regulation of Bile Acid Biosynthesis by Hepatocyte Nuclear Factor 4Α

Lipid-activated transcription factors control bile acid glucuronidation

The role of bile acids in regulating glucose and lipid metabolism.

Exploring the role of a novel postbiotic bile acid: Interplay with gut microbiota, modulation of the farnesoid X receptor, and prospects for clinical translation

Bile Acids and FXR: Novel Targets for Liver Diseases

Advances in the recognition strategies and analytical techniques of bile acids